利用影像特征预测导管原位癌保乳术后同侧乳腺肿瘤复发的列线图
本研究回顾性纳入两家医院接受保乳术的导管原位癌女性,利用临床病理和影像变量构建预测10年同侧乳腺肿瘤复发的列线图,并在外部验证队列中评估。列线图校准良好,验证队列10年AUROC为0.73,与MSKCC列线图的0.66相比无显著差异(P=0.534)。
要点
- 列线图纳入年龄、切缘、辅助放疗、乳腺密度和钙化形态预测10年同侧复发。
- 验证队列中列线图10年AUROC为0.73,MSKCC列线图为0.66,两者比较P=0.534。
- 列线图校准良好,可提供个体化复发风险估计。
核心结论
- 列线图为接受保乳术的导管原位癌女性提供个体化风险估计,区分能力与MSKCC列线图相当。
研究设计与样本
- 回顾性研究,开发队列702例(中位年龄50岁),外部验证队列182例(中位年龄48岁),来自两家医院。
诊断标准与关键数值
- 列线图基于三个临床病理变量(年龄、切缘、辅助放疗使用)和两个乳腺X线变量(乳腺密度、钙化形态)构建。验证队列10年AUROC为0.73,MSKCC列线图为0.66,P=0.534。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a nomogram that integrates clinical-pathologic and imaging variables to predict ipsilateral breast tumor recurrence (IBTR) in women with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS).
MATERIALS AND METHODS: This retrospective study included consecutive women with DCIS who underwent BCS at two hospitals. Patients who underwent BCS between 2003 and 2016 in one hospital and between 2005 and 2013 in another were classified into development and validation cohorts, respectively. Twelve clinical-pathologic variables (age, family history, initial presentation, nuclear grade, necrosis, margin width, number of excisions, DCIS size, estrogen receptor, progesterone receptor, radiation therapy, and endocrine therapy) and six mammography and ultrasound variables (breast density, detection modality, mammography and ultrasound patterns, morphology and distribution of calcifications) were analyzed. A nomogram for predicting 10-year IBTR probabilities was constructed using the variables associated with IBTR identified from the Cox proportional hazard regression analysis in the development cohort. The performance of the developed nomogram was evaluated in the external validation cohort using a calibration plot and 10-year area under the receiver operating characteristic curve (AUROC) and compared with the Memorial Sloan-Kettering Cancer Center (MSKCC) nomogram.
RESULTS: The development cohort included 702 women (median age [interquartile range], 50 [44-56] years), of whom 30 (4%) women experienced IBTR. The validation cohort included 182 women (48 [43-54] years), 18 (10%) of whom developed IBTR. A nomogram was constructed using three clinical-pathologic variables (age, margin, and use of adjuvant radiation therapy) and two mammographic variables (breast density and calcification morphology). The nomogram was appropriately calibrated and demonstrated a comparable 10-year AUROC to the MSKCC nomogram (0.73 vs. 0.66, P = 0.534) in the validation cohort.
CONCLUSION: Our nomogram provided individualized risk estimates for women with DCIS treated with BCS, demonstrating a discriminative ability comparable to that of the MSKCC nomogram.
引用
- Choi BH, Kang S, Cho N, et al. A Nomogram Using Imaging Features to Predict Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ. Korean J Radiol. 2024. PMID: 39344545. doi:10.3348/kjr.2024.0268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。